Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 286 of 6351
-
A digital coach for fall prevention: can an app steady Seniors' steps?
Prevention Not yet recruitingFalls are a health issue that is both common among older adults (affecting 1 in 2 people each year after age 80) and serious due to their traumatic, psychological, and functionally disabling complications. The international literature shows that it is possible to prevent recurren…
Sponsor: University Hospital, Angers • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Radioactive antibody and immunotherapy combo targets recurrent brain cancer
Disease control Not yet recruitingThis phase I trial studies the side effects and best dose of Actimab-A when given together with cemiplimab (REGN2810) in treating patients with glioblastomas that have come back after a period of improvement (recurrent). Actimab-A consists of the monoclonal antibody lintuzumab co…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could CAR-T cells tame autoimmune diseases? early safety trial launches
Disease control Not yet recruitingThis is an open-label, single-dose, prospective, monocenter, Phase I interventional study (not first-in-human) to assess the safety, tolerability, and preliminary efficacy of autologous anti-CD19 CAR-T cells as an advanced therapy medicinal product in adult patients; with severe …
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill aims to keep leukemia away after transplant
Disease control Not yet recruitingRevumenib is a first in class oral menin inhibitor that targets a central oncogenic dependency shared across KMT2Ar, NPM1m, and NUP98r AML. In addition to suppressing leukemogenic transcriptional programs and promoting leukemic differentiation, menin inhibition has been shown to …
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New 5-Drug cocktail aims to tackle High-Risk myeloma
Disease control Not yet recruitingThis study is researching an experimental five-drug combination called etentamig, isatuximab, bortezomib, lenalidomide, and dexamethasone. The study is focused on participants with newly diagnosed multiple myeloma (NDMM) and high-risk disease who are eligible for autologous stem …
Phase 1/2 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Major trial pits drugs vs. surgery vs. stents for failing hearts
Disease control PausedThe ISCHEMIA-HF trial will randomize participants with multivessel coronary artery disease (CAD) with ejection fraction (EF) ≤40% in a 1:2:2 fashion to guideline-directed medical therapy (GDMT):coronary artery bypass grafting (CABG):percutaneous coronary intervention (PCI).
Phase 3 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New cocktail of drugs takes on Hard-to-Treat bladder cancer
Disease control Not yet recruitingThis phase Ib/II trial tests the safety, side effects, and best dose of quemliclustat in combination with enfortumab vedotin and pembrolizumab, and to see how well the combination works for the treatment of bladder, renal pelvis, or ureter urothelial cancer that cannot be removed…
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill aims to ease Parkinson's motor symptoms when added to standard therapy
Disease control Not yet recruitingThe goal of this clinical trial is to learn if this study drug, ENERGI-F705 Tablets, is safe and works to treat participants who have Parkinson's disease and are currently on standard-of-care antiparkinsonian medications. The main question it aims to answer is: Does ENERGI-F705 …
Phase 2 • Sponsor: Energenesis Biomedical Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Eye injection aims to clear fluid in chronic vision disorder
Disease control Not yet recruitingDysregulation of the Angiopoietin-2 (Ang-2)/Tyrosine kinase with Immunoglobulin-like and EGF-like domains 2 (Tie-2) signaling pathway has been implicated in choroidal vascular instability and RPE dysfunction in Central serous chorioretinopathy (CSCR) and pachychoroid-associated n…
Phase 2 • Sponsor: Singapore National Eye Centre • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Zapping the heart back to rhythm: a new device uses pulsed fields to treat atrial fibrillation
Disease control Not yet recruitingThis study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a weekend retreat help prevent suicide in women veterans?
Prevention Not yet recruitingGiven their elevated risk for suicide and barriers to engaging in VHA healthcare, violence-exposed women Veterans represent a specialized population for which expansions to current VHA programming are needed. This pilot study is to assess the feasibility, acceptability, and preli…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Can a tiny implant track glucose, ketones, and lactate in diabetes?
Diagnosis Not yet recruitingThe purpose of the BRIGHT study is to evaluate safety and performance of the HALO SYSTEM in subjects with diabetes mellitus. The primary objectives of this clinical investigation are 1) the evaluation of sensor's performance by demonstrating sensor's accuracy and stability and 2)…
Sponsor: Indigo Diabetes NV • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Can a silicone sensor shield preterm Babies' fragile skin?
Disease control Not yet recruitingNeonates, especially when born prematurely, have an inherently fragile skin, due to the overall prematurity and to the immature composition of epidermidis and skin dermal structures. In these patients, skin lesions are a frequent entry site for pathogens that may disseminate into…
Sponsor: Paolo Manzoni Study Group • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a customized talk therapy lift depression in autistic teens?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY) can improve depressive symptoms and related mechanisms in autistic youth aged 11-17 years with depression receiving care in outpatient clinical settings. The ma…
Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a 'Scoring' balloon unclog leg arteries better and reduce stents?
Disease control Not yet recruitingThe aim of this clinical trial is to determine whether vessel preparation with a non-compliant scoring balloon before drug-coated balloon (DCB) angioplasty provides superior procedural and clinical outcomes compared with vessel preparation using a non-compliant plain balloon in p…
Sponsor: Marc Sirvent • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Zapping a deep brain region might boost social understanding in autism
Symptom relief Not yet recruitingDespite decades of research, no definitive, effective biological treatments exist for core symptoms of Autism Spectrum Disorder (ASD). Emerging evidence suggests that conventional Transcranial Magnetic Stimulation (TMS) targeting the dorsolateral prefrontal cortex or posterior su…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Gout drug may take the sting out of knee replacement recovery
Symptom relief Not yet recruitingThis study is a prospective, randomized, double-blinded, placebo-controlled study of the drug colchicine in the acute postoperative period for patients who are undergoing a total knee arthroplasty (TKA). Patients aged 18 years or older who are undergoing TKA will be invited to pa…
Phase 4 • Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New hope for Alzheimer's? phase 3 trial of brain-fueling compound begins
Disease control Not yet recruitingThe purpose of this study is to evaluate the effects of tricaprilin (20 g twice a day) on cognition, global function, activities of daily living, resource utilisation, safety, and tolerability, in participants with mild to moderate AD dementia. This is a randomised, double-blind…
Phase 3 • Sponsor: Cerecin • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can tracking symptoms improve care for children with advanced cancer?
Knowledge-focused Not yet recruitingThe goal of this observational study is to understand how cancer makes children feel over time. The main things the researchers hope to learn are: * When and how often do children have different feelings or sickness; * Why do these feelings happen; and, * How these feelings chan…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Sponge on a string and AI could revolutionize esophageal cancer screening
Diagnosis Not yet recruitingThis clinical trial studies how well minimally invasive approaches (an artificial intelligence \[AI\] powered risk tool, nurse navigation, and a sponge on a string \[SOS\] test) work in diagnosing patients with Barrett's esophagus (BE) and esophageal cancer. Esophageal cancer has…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC